SEC ownership of U S PHYSICAL THERAPY INC /NV

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000885978.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

BlackRock, Inc.

Comparable rows

5/50

Latest evidence

30 Sep 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
5 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Sep 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000885978
Issuer location
Houston, TX

Ownership snapshot

Top shareholders of U S PHYSICAL THERAPY INC /NV (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
5/50
Latest evidence
30 Sep 2026
13D/G 13F 3/4/5 Lead comparable stake: 14% 45 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-8 of 50 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 14%.

5 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 14%
Copeland Capital Management, LLC 6.3%
KAYNE ANDERSON RUDNICK INVESTMENT... 5.6%
VANGUARD CAPITAL MANAGEMENT LLC 5.1%
MORGAN STANLEY 3.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
14%
Reported 13D/G · 30 Jun 2025
$169,079,035
2,162,136 shares
$0 30 Jun 2025
Copeland Capital Management, LLC
13D/G 13F
Company
6.3%
Reported 13D/G · 30 Sep 2026
$80,633,817
940,528 shares
+$8,486,146 30 Sep 2026
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
13D/G 13F
Company
5.6%
Reported 13D/G · 30 Jun 2026
$62,188,205
846,674 shares
-$26,869,479 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5.1%
Reported 13D/G · 31 Mar 2026
$58,731,373
777,590 shares
$0 31 Mar 2026
MORGAN STANLEY
13F 13D/G
Company
3.9%
Reported 13D/G · 30 Jun 2026
$47,986,138
698,690 shares
— 30 Jun 2026
Bahl & Gaynor LLC
13F
Company
13F
—
denominator unverified
$59,172,902
861,574 shares
— 30 Jun 2026
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$48,578,366
707,186 shares
— 30 Jun 2026
Neuberger Berman Group LLC
13F
Company
13F
—
denominator unverified
$41,132,040
598,894 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$173,339.

Buys
$325,251
Insiders: 2
Sells
$498,590
Insiders: 2
Net
-$173,339
Shares: -1,427
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 4,786 Shares: 6,213
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 5.27 0 $416 $0 +$416
3-6 781 0 $48,835 $0 +$48,835
6-9 0 5,470 $0 $445,830 -$445,830
9-12 4,000 743 $276,000 $52,760 +$223,240

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 20 reporting-owner rows connected to U S PHYSICAL THERAPY INC /NV. Open a relationship link for the CIK-to-CIK filing trail.

Rows
20
Largest Forms 3/4/5 holder
Christopher J. Reading
Net 12M change
-$173,339
Latest report
01 Oct 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Christopher J. Reading Chairman of the Board and CEO, Director $11,922,623 Mixed 23 Feb 2026
Eric Joseph Williams President and COO $2,720,895 Mixed 20 Aug 2026
Carey P. Hendrickson Chief Financial Officer $2,434,312 Mixed 09 Mar 2026
Kathleen A. Gilmartin Director $2,030,816 +$276,000 +16% Mixed 19 May 2026
Graham D. Reeve Coo $1,961,088 -$253,670 -11% Mixed 20 Aug 2026
Regg E. Swanson Director $1,730,676 Mixed 19 May 2026
Richard Binstein EVP Gen'l Counsel & Secretary $1,676,959 -$244,920 -13% Mixed 20 Aug 2026
Bernard A. Harris Jr. Director $1,567,713 Mixed 19 May 2026
Glenn McDowell Chief Operating Officer $1,279,369 Mixed 31 Aug 2021
Mark J. Brookner Director $1,275,956 Mixed 15 Nov 2022
Michael Glasser Mayrsohn Director $1,238,247 Mixed 20 May 2025
Anne B. Motsenbocker Director $735,507 Mixed 19 May 2026
Harry S. Chapman Director $621,832 Mixed 16 Dec 2022
Clayton Trier Director $560,239 Mixed 20 May 2025
Nchacha Etta EVP & Chief Financial Officer $469,153 Mixed 14 Sep 2026
Edward L. Kuntz Director $352,830 Filing P/S 15 May 2024
Jason Travis Curtis Interim CFO $264,624 Mixed 20 Aug 2026
Peter F. Minan Director $254,154 +$49,251 +24% Filing P/S 12 Jun 2026
Nancy Ham Director $162,929 Filing P/S 11 Sep 2025
Myra Davis Director $83,102 Mixed 01 Oct 2026

Recent insider transactions for U S PHYSICAL THERAPY INC /NV

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Myra Davis USPH Common Stock Award 1,210 1,210 01 Oct 2026 Direct
Nchacha Etta USPH Common Stock Award 6,831 6,831 14 Sep 2026 Direct
Peter Francis Minan USPH Common Stock Purchase 0.16% $416 $79.00 5.27 3,217 11 Sep 2026 Direct
Eric Joseph Williams USPH Common Stock Tax liability -1.77% -714 39,617 20 Aug 2026 Direct
Jason Travis Curtis USPH Common Stock Tax liability -1.03% -40 3,853 20 Aug 2026 Direct
Richard Binstein USPH Common Stock Tax liability -1.81% -450 24,417 20 Aug 2026 Direct
Graham D. Reeve USPH Common Stock Tax liability -2.6% -762 28,554 20 Aug 2026 Direct
Peter Francis Minan USPH Common Stock Purchase 0.03% $57.86 $66.50 0.87 3,212 12 Jun 2026 Direct
Peter Francis Minan USPH Common Stock Purchase 9.85% $17,712 $61.50 288 3,211 09 Jun 2026 Direct
Peter Francis Minan USPH Common Stock Purchase 20.2% $31,065 $63.14 492 2,923 08 Jun 2026 Direct
Jason Travis Curtis USPH Common Stock Tax liability -1.02% -40 3,893 20 May 2026 Direct
Graham D. Reeve USPH Common Stock Tax liability -2.53% -762 29,316 20 May 2026 Direct
Regg E. Swanson USPH Common Stock Award 17.5% 2,306 15,492 19 May 2026 Direct
Anne Motsenbocker USPH Common Stock Award 30.7% 2,306 9,812 19 May 2026 Direct
Peter Francis Minan USPH Common Stock Award 1844.8% 2,306 2,431 19 May 2026 Direct
Bernard A. Harris Jr. USPH Common Stock Award 12.4% 2,306 20,914 19 May 2026 Direct
Kathleen A. Gilmartin USPH Common Stock Award 9.3% 2,306 27,092 19 May 2026 Direct
Graham D. Reeve USPH Common Stock Sale -2.15% $52,205 $78.86 -662 30,078 11 Mar 2026 Direct
Graham D. Reeve USPH Common Stock Sale -100% $78.52 $78.52 -1 0 09 Mar 2026 Reeve Trust
Carey P. Hendrickson USPH Common Stock Disposed to Issuer -26.4% -10,000 27,808 09 Mar 2026 Direct
Graham D. Reeve USPH Common Stock Sale -99.9% $148,626 $82.25 -1,807 1 06 Mar 2026 Reeve Trust
Richard Binstein USPH Common Stock Sale -10.8% $244,920 $81.64 -3,000 24,867 06 Mar 2026 Direct
Christopher J. Reading USPH Common Stock Award 21.9% 25,000 139,088 23 Feb 2026 Direct
Eric Joseph Williams USPH Common Stock Award 59.2% 15,000 40,331 23 Feb 2026 Direct
Graham D. Reeve USPH Common Stock Award 48.2% 10,000 30,740 23 Feb 2026 Direct
Richard Binstein USPH Common Stock Award 56% 10,000 27,867 23 Feb 2026 Direct
Carey P. Hendrickson USPH Common Stock Award 36% 10,000 37,808 23 Feb 2026 Direct
Graham D. Reeve USPH Common Stock Sale -3.46% $52,760 $71.01 -743 20,740 24 Nov 2025 Direct
Kathleen A. Gilmartin USPH Common Stock Purchase 19.2% $276,000 $69.00 4,000 24,786 20 Nov 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .